CAS: 2381037-82-5
RBN-2397
CAS:2381037-82-5
RBN-2397 is a potent, selective and orally active accross species NAD+ competitive PARP7 inhibitor with …
Fórmula:
C20H23F6N7O3
Pureza:
99.96%
Forma y color:
Solid
Peso molecular:
523.43
Ref: TM-T12695
1mg | 162,00 € | |
5mg | 386,00 € | |
10mg | 574,00 € | |
25mg | 919,00 € | |
50mg | 1.236,00 € | |
100mg | 1.663,00 € | |
500mg | 3.344,00 € | |
1ml*10 (DMSO) | 424,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Mayo de 2024
5-[[(1S)-1-methyl-2-[3-oxo-3-[4-[5-(trifluoromethyl)-2-pyrimidinyl]-1-piperazinyl]propoxy]ethyl]amino]-4-(trifluoromethyl)-3(2H)-pyridazinone
CAS:2381037-82-5
Fórmula:
C20H23F6N7O3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
523.4321
Ref: AN-AG01KBK1
1mg | 56,00 € | |
5mg | 90,00 € | |
10mg | 125,00 € | |
25mg | 145,00 € | |
50mg | 242,00 € | |
100mg | 544,00 € | |
250mg | 652,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Mayo de 2024
RBN-2397
CAS:2381037-82-5
RBN-2397 is a poly-adp-ribose polymerase inhibitor that has been shown to have clinical efficacy in …
Fórmula:
C20H23F6N7O3
Pureza:
Min. 95%
Peso molecular:
523.4 g/mol
Ref: 3D-GVD03782
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 12 de Junio de 2024